Ohio Department of Health sounds alarm as measles outbreak grows in Ashtabula County
The Ohio Department of Health said the outbreak is linked to one man, the first case of measles in 2025.
Manhunt suspended for James Douglas Meadows, suspect in Lorain County police officer assault who is still at-large
The man recently traveled, and the area is not being shared by the Ashtabula County Health Department, to protect the anonymity of the man. The nine new cases are linked to that same man and all of the individuals are not vaccinated.
ODH said measles is a growing concern as cases continue to spike in Western Texas and New Mexico.
'Given the measles activity in Texas, New Mexico, and other states around the country, we're disappointed but not surprised we now have several cases here in Ohio and known exposure in some counties,' ODH Director Dr. Bruce Vanderhoff said. 'This disease can be very serious, even deadly, but it is almost entirely avoidable by being properly vaccinated. Measles is especially dangerous for young children, so I strongly urge all parents across Ohio to make sure your children are vaccinated. It is a crucial layer of protection that can save lives.'
There is an additional confirmed case in Knox County, Ohio, as well.
Guardians reach TV Deal: Here's how to watch
The Centers for Disease Control and Prevention (CDC) defines a measles outbreak as three or more related cases. Measles can spread quickly, and each case can lead to an additional 12 to 18 cases if people aren't protected against the disease. The CDC reported 378 cases nationwide as of March 20.
Ohio had 90 cases of measles in 2022, when an outbreak in central Ohio totaled 85 cases. The state had one measles case in 2023 and seven in 2024.
Measles is extremely contagious and can spread to others through coughing and sneezing. It can be brought into Ohio by individuals who travel to places where measles is spreading. If people are not protected against the disease, nine out of 10 people who are exposed will become ill.
The measles virus can live up to two hours in the air after an infected person leaves the room. Symptoms usually appear 7-14 days after a person comes in contact with the virus but it can take as long as 21 days in some cases.
RECALL: Metal found in beef sticks sold nationwide, says USDA
The measles vaccine (called MMR as it protects against measles, mumps and rubella) is safe and effective at preventing measles. Two doses of MMR are 97% effective against measles. If you are up to date on the measles vaccine, the risk of getting sick is extremely low.
ACHD will take part in a Vaccination Clinic for Measles-Mumps-Rubella, Varicella, DTaP, Polio & Flu for Adults and Children on Thursday, March 27, from 3:30-5:30 pm at the Conneaut Human Resource Center, 327 Mill St., Conneaut, OH 44030. No appointment is required. Bring insurance cards and shot records if you have them. Some vaccines are available at no cost for those who qualify. A parent must accompany any minor. Call (440)576-6010, option #2, for more information.
Dr. Vanderhoff held a news conference on March 18 to discuss Ohio's childhood immunization rates and to urge parents to get their children up to date on all recommended vaccines, including the MMR vaccine. You can find the video of that news conference on the ODH YouTube channel.
More information about measles is available on the CDC website, including general information and the recommended immunization schedule. ODH also has a measles FAQ page.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Los Angeles Times
5 hours ago
- Los Angeles Times
Amid widespread measles outbreak, infectious traveler confirmed at LAX, nearby hotel
An out-of-country traveler who passed through Los Angeles International Airport this month and stayed in a local hotel was confirmed to have measles, health officials announced Thursday. L.A. County Department of Public Health officials are investigating two sites in Los Angeles the man visited while infectious, according to a news release. Public spaces where others may have been exposed to the infection are LAX and the Hilton Los Angeles Airport, at 5711 W. Century Blvd. The person landed July 5 at LAX; the exact time and flight information were still being investigated, according to the department. The infected individual was at the Hilton from 7:30 p.m. July 5 until checking out at 1 p.m. July 7. Individuals who were at these locations on these days are urged by the department to monitor potential symptoms for at least three weeks. Symptoms include high fever, coughs, or red, watery eyes, according to the Centers for Disease Control and Prevention. They're also urged to confirm their MMR (measles, mumps and rubella) vaccination status. Those who have not been immunized are at higher risk of infection. As The Times reported last month, the U.S. is in the midst of its largest outbreak of measles in decades, with California already reporting more cases of the disease than in all of last year. As outbreaks ramp up within the U.S. and internationally, the release said, summer travel can heighten exposure and transmission levels. 'Measles is a highly contagious respiratory illness that can linger in the air and on surfaces, making it easy to spread, particularly among people who are not already protected from it,' said Dr. Muntu Davis, Los Angeles County health officer. 'A person can spread the illness to others before they have symptoms, and it can take seven to 21 days for symptoms to show up after exposure.' The department encouraged all residents to review their immunization records, contact their healthcare provider about potential exposure — especially if they are pregnant or have a weakened immune system — and avoid large gatherings if symptoms arise. Davis said, however, that the most effective preventive measure against measles is immunization. 'The best way to protect yourself and your family from infection is with the highly effective measles vaccine,' he said.
Yahoo
9 hours ago
- Yahoo
Primus Sounds Alarm on Chronic Venous Insufficiency as President Trump's Diagnosis Sparks National Focus
SCOTTSDALE, ARIZONA / / July 24, 2025 / Following reports of President Donald J. Trump's diagnosis with Chronic Venous Insufficiency (CVI), Primus Pharmaceuticals, Inc. strongly calls on healthcare providers to intensify efforts to diagnose and treat this silent epidemic affecting 25-30 million Americans because only less than <10% are actually treated. Leg swelling, heaviness, and varicose veins are often dismissed as cosmetic or "normal aging," while they can signal a dangerous progression toward severe complications including thromboembolism (blood clots), debilitating pain, non-healing leg ulcers, and compromised mobility. Widespread, Under-Recognized Health Threat CVI, also known as chronic venous disease or venous reflux disease, impacts twice (2x) as many Americans as coronary heart disease, three times (3x) peripheral arterial disease, and 30 times (30x) the number of Americans who have a heart attack each year. According to CDC, up to 900,000 Americans are affected by venous thromboembolism annually, and 60,000 to 100,000 people die each year. Millions suffer daily challenges - standing, sitting, flying - due to blood pooling in the legs, worsened by inactivity or pressure. Traditional treatments - leg elevation, compression stockings or surgical procedures - are often cumbersome, uncomfortable, underutilized, and may be expensive with added health risks. Life-Changing Solution: Vasculera® Primus offers Vasculera, the only U.S. prescription product for CVI. It is specifically formulated as a medical food for the clinical dietary management of CVI. Taken once daily, this 600mg tablet delivers highly purified, bioavailable diosmin, a flavonoid sourced from oranges, in combination with a pH buffering agent and: Calms inflammation and oxidative stress Strengthens weakened vein walls Improves overall venous function Counters localized CVI blood acidosis Manufactured in the U.S., Vasculera presents a novel naturally-derived alternative to the status quo. Expert Physician Perspectives "CVI and its manifestation in skin known as stasis dermatitis is a very common condition that can lead to significant impairment and morbidity," said Dr. Mark Nestor, MD, PhD, Board-certified Dermatologist and Voluntary Professor, Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine. "Diosmin in its bioavailable form in the pharmaceutical-grade medical food Vasculera is a natural flavonoid that has scientifically proven benefit for this condition." Board-certified Vascular Surgeon Dr. Ron Bush, MD, FACS, one of the world's foremost experts in the histology and treatment of venous disease states, "CVI is a common condition, with symptoms that may vary but are consistently linked to elevated venous pressure. In my clinical experience, Vasculera has proven to be an effective treatment option. Its active ingredient, diosmin, is well-studied and widely documented for its ability to address the inflammation associated with chronic venous hypertension. Vasculera is also well-tolerated and has no significant contraindications." Robust Clinical Backing Over 60 published peer-reviewed clinical studies confirm diosmin's effectiveness in reducing leg pain, swelling, and skin deterioration associated with CVI. Vascular medicine experts recommend Vasculera's ultra-micronized diosmin as the only U.S. product for venous ulcers and CVI symptoms, both as standalone and adjunctive therapy in national treatment guidelines. Public Health Call to Action With an aging population and more time on electronic devices fueling CVI's prevalence, Primus urges clinicians to: Proactively screen all at-risk patients for CVI Integrate proven prescription metabolic therapies like Vasculera with CVI standards of care For prescribing information, visit About Primus Pharmaceuticals Primus innovates in prescription nutritional therapies targeting metabolic causes of chronic diseases across rheumatology, dermatology, and women's health. We develop and commercialize first-in-class products and novel deliveries in Rx drugs, medical foods, and medical devices to fill key unmet needs with universal patient access not provided by traditional pharma. Visit Contact Information Randy Keating Public Relations Managerrkeating@ SOURCE: Primus Pharmaceuticals View the original press release on ACCESS Newswire Sign in to access your portfolio
CBS News
15 hours ago
- CBS News
Third human case of West Nile virus in Illinois reported in DuPage County
A Third human case of West Nile virus in Illinois has been reported, this time in DuPage County. The DuPage County Health Department confirmed the case on Thursday. The department said the individual is a Glen Ellyn resident in their 50s, and the onset of symptoms was mid-July. The Centers for Disease Control and Prevention first confirmed in June that a person downstate, specifically in Southern Illinois, was hospitalized due to complications of the virus. The second was confirmed in Lake County on July 16. The resident was said to be in their 70s and became ill earlier in the month. Symptoms of West Nile virus While most people infected with the virus do not feel sick, about one in five will develop a fever and flu-like symptoms. Other symptoms include body aches, vomiting, diarrhea, or rash. Severe illness can occur in about one in 150 people and is most likely to occur in people over age 55 or with weakened immune systems. How to prevent it West Nile virus is spread to people from infected mosquitoes, most commonly in the summer. Eight out of 10 people infected do not develop symptoms, according to the CDC. Residents are also reminded to practice the three "R's"– reduce the number of mosquitoes and remove containers outside that hold water, repel mosquitoes by using insect repellent, and report areas where water sits for more than a week. There are no medications to treat the virus. The only way to combat the virus is to prevent mosquito bites.
